drugset
drugset / Trial / NCT01035515

BIIB014 Cardiovascular Monitoring Study

NCT01035515 ↗

Phase 1 Completed 24 enrolled Biogen
RandomizedCrossoverDouble-blind

Summary

The study will examine the effects of a single dose of BIIB014 on blood pressure and haemodynamic variables in healthy volunteers over 24 hours.

Timeline

Start
2009-12
Primary completion
2010-04
Completion
2010-04

Drugs

EvaluationDrugModalityDoseRoute
Subject VIPADENANT Small molecule 50 mg Oral
Subject VIPADENANT Small molecule 100 mg Oral

Indications

No indication recorded.